{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T21:10:59Z","timestamp":1772572259561,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T00:00:00Z","timestamp":1567814400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T00:00:00Z","timestamp":1567814400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s11239-019-01951-5","type":"journal-article","created":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T07:02:45Z","timestamp":1567839765000},"page":"75-85","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Age-related burden and characteristics of embolic stroke of undetermined source in the real world clinical practice"],"prefix":"10.1007","volume":"49","author":[{"given":"Elisa","family":"Grifoni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide","family":"Giglio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Guazzini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleonora","family":"Cosentino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ester","family":"Latini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Dei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Attilio","family":"Del Rosso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Guarnaccia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariella","family":"Baldini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Letizia","family":"Bartolozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietro","family":"Martinucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Sani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Dainelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Maggi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Giulietti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Romagnoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Cinotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Schipani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe Salvatore","family":"Murgida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Di Martino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Cozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adele","family":"Carli Ballola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debora","family":"Dacomo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debora","family":"Valori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1208-9343","authenticated-orcid":false,"given":"Luca","family":"Masotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,9,7]]},"reference":[{"key":"1951_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1755-5949.2011.00292.x","volume":"00","author":"PH Chen","year":"2012","unstructured":"Chen PH, Gao S, Wang YJ et al (2012) Classyfing ischemic stroke, from TOAST to CISS. CNS Neurosci Ther 00:1\u20135. \nhttps:\/\/doi.org\/10.1111\/j.1755-5949.2011.00292.x","journal-title":"CNS Neurosci Ther"},{"key":"1951_CR2","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","volume":"24","author":"HP Adams Jr","year":"1993","unstructured":"Adams HP Jr, Bendixen BH, Kappelle LJ et al (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24:35\u201341","journal-title":"Stroke"},{"key":"1951_CR3","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S1474-4422(13)70310-7","volume":"13","author":"RG Hart","year":"2014","unstructured":"Hart RG, Diener HC, Coutts SB, for the Cryptogenic Stroke\/ESUS International Working Group et al (2014) Embolic strokes of undetermined source: the case for a new clinical construct. Lancet Neurol 13:429\u2013438. \nhttps:\/\/doi.org\/10.1016\/S1474-4422(13)70310-7","journal-title":"Lancet Neurol"},{"key":"1951_CR4","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1161\/STROKEAHA.116.016414","volume":"48","author":"RG Hart","year":"2017","unstructured":"Hart RG, Catanese L, Perera KS et al (2017) Embolic stroke of undetermined source. A systematic review and clinical update. Stroke 48:867\u2013872. \nhttps:\/\/doi.org\/10.1161\/STROKEAHA.116.016414","journal-title":"Stroke"},{"key":"1951_CR5","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","volume":"3","author":"S Schulman","year":"2005","unstructured":"Schulman S, Kearon C, Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis (2005) Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost 3:692\u2013694. \nhttps:\/\/doi.org\/10.1111\/j.1538-7836.2005.01204.x","journal-title":"J Thromb Haemost"},{"key":"1951_CR6","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1212\/WNL.47.5.1125","volume":"47","author":"L Tatu","year":"1996","unstructured":"Tatu L, Moulin T, Bogousslavsky J et al (1996) Arterial territories of the human brain: brainstem and cerebellum. Neurology 47:1125\u20131135","journal-title":"Neurology"},{"key":"1951_CR7","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1212\/WNL.50.6.1699","volume":"50","author":"L Tatu","year":"1998","unstructured":"Tatu L, Moulin T, Bogousslavsky J et al (1998) Arterial territories of the human brain: cerebral hemispheres. Neurology 50:1699\u20131708","journal-title":"Neurology"},{"key":"1951_CR8","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1161\/STROKEAHA.116.013378","volume":"47","author":"KS Perera","year":"2016","unstructured":"Perera KS, Vanassche T, Bosch J, Global Registry Investigators ESUS et al (2016) Global survey of the frequency of atrial fibrillation associated stroke: embolic stroke of undetermined source global registry. Stroke 47:2197\u20132202. \nhttps:\/\/doi.org\/10.1161\/STROKEAHA.116.013378","journal-title":"Stroke"},{"key":"1951_CR9","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1177\/1747493016641967","volume":"11","author":"KS Perera","year":"2016","unstructured":"Perera KS, Vanassche T, Bosch J et al (2016) Embolic strokes of undetermined source: prevalence and patient features in the ESUS Global Registry. Int J Stroke 11:526\u2013533. \nhttps:\/\/doi.org\/10.1177\/1747493016641967","journal-title":"Int J Stroke"},{"key":"1951_CR10","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1161\/STROKEAHA.115.009334","volume":"46","author":"G Ntaios","year":"2015","unstructured":"Ntaios G, Papavasileiou V, Milionis H et al (2015) Embolic strokes of undetermined source in the Athens stroke registry: an outcome analysis. Stroke 46:2087\u20132093. \nhttps:\/\/doi.org\/10.1161\/STROKEAHA.115.009334","journal-title":"Stroke"},{"key":"1951_CR11","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1093\/eurheartj\/ehx042","volume":"38","author":"IC Van Gelder","year":"2017","unstructured":"Van Gelder IC, Healey JS, Crijns HJGM et al (2017) Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT. Eur Heart J 38:1339\u20131344. \nhttps:\/\/doi.org\/10.1093\/eurheartj\/ehx042","journal-title":"Eur Heart J"},{"key":"1951_CR12","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1161\/CIRCEP.109.849638","volume":"2","author":"TV Glotzer","year":"2009","unstructured":"Glotzer TV, Daoud EG, Wyse DG et al (2009) The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study. Circ Arrhythm Electrophysiol 2:474\u2013480. \nhttps:\/\/doi.org\/10.1161\/CIRCEP.109.849638","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"1951_CR13","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1093\/eurheartj\/ehv115","volume":"36","author":"DT Martin","year":"2015","unstructured":"Martin DT, Bersohn MM, Waldo AL et al (2015) Randomized trial of atrial arrhythmia monitoring to guide anticoagulation in patients with implanted defibrillator and cardiac resynchronization devices. Eur Heart J 36:1660\u20131668. \nhttps:\/\/doi.org\/10.1093\/eurheartj\/ehv115","journal-title":"Eur Heart J"},{"key":"1951_CR14","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1093\/europace\/euw161","volume":"18","author":"A Goette","year":"2016","unstructured":"Goette A, Kalman JM, Aguinaga L et al (2016) EHRA\/HRS\/APHRS\/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication. Europace 18:1455\u20131490. \nhttps:\/\/doi.org\/10.1093\/europace\/euw161","journal-title":"Europace"},{"key":"1951_CR15","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.jacc.2017.06.033","volume":"70","author":"J-B Guichard","year":"2017","unstructured":"Guichard J-B, Nattel S (2017) Atrial cardiomyopathy: a useful notion in cardiac disease management or a passing fad? J Am Coll Cardiol 70:756\u2013765. \nhttps:\/\/doi.org\/10.1016\/j.jacc.2017.06.033","journal-title":"J Am Coll Cardiol"},{"key":"1951_CR16","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.01.028","volume":"27","author":"B Ricci","year":"2018","unstructured":"Ricci B, Chang AD, Hemendinger M et al (2018) A simple score that predicts paroxysmal atrial fibrillation on outpatient cardiac monitoring after embolic stroke of unknown source. J Stroke Cerebrovasc Dis 27:1692\u20131696. \nhttps:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2018.01.028","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"1951_CR17","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1007\/s11239-018-1775-2","volume":"47","author":"L Masotti","year":"2019","unstructured":"Masotti L, Grifoni E, Dei A et al (2019) Direct oral anticoagulants in the early phase of non valvular atrial fibrillation-related acute ischemic stroke: focus on real life studies. J Thromb Thrombolysis 47:292\u2013300. \nhttps:\/\/doi.org\/10.1007\/s11239-018-1775-2","journal-title":"J Thromb Thrombolysis"},{"key":"1951_CR18","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1161\/01.STR.0000016922.22707.27","volume":"33","author":"GJ Hankey","year":"2002","unstructured":"Hankey GJ (2002) Warfarin-Aspirin Recurrent Stroke Study (WARSS) trial: is warfarin really a reasonable therapeutic alternative to aspirin for preventing recurrent noncardioembolic ischemic stroke? Stroke 33:1723\u20131726","journal-title":"Stroke"},{"key":"1951_CR19","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1159\/000092331","volume":"22","author":"RL Sacco","year":"2006","unstructured":"Sacco RL, Prabhakaran S, Thompson JLP et al (2006) Comparison of warfarin versus aspirin for the prevention of recurrent stroke or death: subgroup analyses from the Warfarin-Aspirin Recurrent Stroke Study. Cerebrovasc Dis 22:4\u201312. \nhttps:\/\/doi.org\/10.1159\/000092331","journal-title":"Cerebrovasc Dis"},{"key":"1951_CR20","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1056\/NEJMoa1802686","volume":"378","author":"RG Hart","year":"2018","unstructured":"Hart RG, Sharma M, Mundl H et al (2018) Rivaroxaban for stroke prevention after embolic stroke of undetermined source. N Engl J Med 378:2191\u20132201. \nhttps:\/\/doi.org\/10.1056\/NEJMoa1802686","journal-title":"N Engl J Med"},{"key":"1951_CR21","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1056\/NEJMoa1813959","volume":"380","author":"HC Diener","year":"2019","unstructured":"Diener HC, Sacco RL, Easton JD, RE-SPECT ESUS Steering Committee and Investigators et al (2019) Dabigatran for prevention of stroke after embolic stroke of undetermined source. N Engl J Med 380:1906\u20131917. \nhttps:\/\/doi.org\/10.1056\/NEJMoa1813959","journal-title":"N Engl J Med"},{"key":"1951_CR22","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1177\/1747493016681019","volume":"12","author":"T Geisler","year":"2017","unstructured":"Geisler T, Poli S, Meisner C et al (2017) Apixaban for treatment of embolic stroke of undetermined source (ATTICUS randomized trial): rationale and study design. Int J Stroke 12:985\u2013990. \nhttps:\/\/doi.org\/10.1177\/1747493016681019","journal-title":"Int J Stroke"},{"key":"1951_CR23","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1177\/1747493018799981","volume":"14","author":"H Kamel","year":"2019","unstructured":"Kamel H, Longstreth WT, Tirschwell DL et al (2019) The atrial cardiopathy and antithrombotic drugs in prevention after cryptogenic stroke randomized trial: rationale and methods. Int J Stroke 14:207\u2013214. \nhttps:\/\/doi.org\/10.1177\/1747493018799981","journal-title":"Int J Stroke"},{"key":"1951_CR24","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/S1474-4422(18)30319-3","volume":"17","author":"SE Kasner","year":"2018","unstructured":"Kasner SE, Swaminathan B, Lavados P et al (2018) Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial. Lancet Neurol 17:1053\u20131060. \nhttps:\/\/doi.org\/10.1016\/S1474-4422(18)30319-3","journal-title":"Lancet Neurol"},{"key":"1951_CR25","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2019.0617","author":"JS Healey","year":"2019","unstructured":"Healey JS, Gladstone DJ, Swaminathan B et al (2019) Recurrent stroke with rivaroxaban compared with aspirin according to predictors of atrial fibrillation: secondary analysis of the NAVIGATE ESUS Randomized clinical trial. JAMA Neurol. \nhttps:\/\/doi.org\/10.1001\/jamaneurol.2019.0617","journal-title":"JAMA Neurol"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-019-01951-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11239-019-01951-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-019-01951-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,5]],"date-time":"2020-09-05T23:52:54Z","timestamp":1599349974000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-019-01951-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,7]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["1951"],"URL":"https:\/\/doi.org\/10.1007\/s11239-019-01951-5","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,7]]},"assertion":[{"value":"7 September 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}